Disease Testing in Chronic Lymphocytic Leukemia
1 Views
administrator
07/08/23
Dr. Sharman comments on the role of minimal residual disease (MRD) testing in relpased chronic lymphocytic leukemia, and the likelihood of length of response to treatment.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
-
Category
Show more
Facebook Comments
No comments found